Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|June 4, 2015
Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn miceShiyang Sun, Fan Gao, Qunying Mao, et al.Microbiology Spectrum|October 31, 2022
Serum Proteomic Analysis for New Types of Long-Term Persistent COVID-19 Patients in WuhanCuidan Li, Liya Yue, Yingjiao Ju, et al.Plos One|July 22, 2017
Characterization of human enterovirus71 virus-like particles used for vaccine antigensDandan Zhao, Bo Sun, Shiyang Sun, et al.Human Vaccines & Immunotherapeutics|December 9, 2014
Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn miceShiyang Sun, Liping Jiang, Zhenglun Liang, et al.Plos One|June 26, 2014
Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assayHuafei Zhang, Dong An, Wei Liu, et al.Antiviral Research|September 19, 2024
Modulating apoptosis as a novel therapeutic strategy against Respiratory Syncytial Virus infection: insights from RotenoneKe Zhang, Xiao-Meng Yang, Haoran Sun, et al.Nature Communications|November 1, 2025
Live attenuated influenza vaccine with low proportions of defective interfering particles elicits robust immunogenicity and cross-protectionMin Wu, Peihan Wang, Likun Wang, et al.Genomics, Proteomics & Bioinformatics|August 12, 2025
Macrophage Response to Avirulent and Virulent Mycobacterium tuberculosis and Anti-TB Effects of Exosome TreatmentLi Yang, Lingna Lyu, Cuidan Li, et al.Journal of Virology|August 13, 2011
Primary infection by a human immunodeficiency virus with atypical coreceptor tropismChunlai Jiang, Nicholas F Parrish, Craig B Wilen, et al.Nature Communications|May 17, 2018
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infectionHongshuo Song, Elena E Giorgi, Vitaly V Ganusov, et al.Pageof 11